Clinical Observation of Icotinib Hydrochloride in First-line Therapy 
for Pulmonary Adenocarcinoma

Background and objective It has been proven that icotinib hydrochloride, as a molecule targeted drug, can be safely and efficiently used to treat advanced non-small cell lung cancer (NSCLC) for second-line or third-line. This research was aimed to investigate the efficacy and toxicity of icotinib hy...

Descripción completa

Detalles Bibliográficos

Autores principales:	Xinjie YANG, Hui ZHANG, Na QIN, Xi LI, Jingying NONG, Jialin LV, Yuhua WU, Quan ZHANG, Shucai ZHANG
Formato:	Artigo
Lenguaje:	Chinês
Publicado:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-07-01
Colección:	Chinese Journal of Lung Cancer
Materias:	Lung neoplasms Icotinib hydrochloride First-line therapy Adenocarcinoma
Acceso en línea:	http://dx.doi.org/10.3779/j.issn.1009-3419.2013.07.06
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!